Corium International (Corium International) Intangible Assets : $7.40 Mil (As of Jun. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Corium International Intangible Assets?

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Corium International's intangible assets for the quarter that ended in Jun. 2018 was $7.40 Mil.

Corium International Intangible Assets Historical Data

The historical data trend for Corium International's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corium International Intangible Assets Chart

Corium International Annual Data

Trend

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Intangible Assets

Get a 7-Day Free Trial

6.65

6.68

6.85

7.06

7.12

Corium International Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
Intangible Assets	Get a 7-Day Free Trial															7.36	7.12	7.15	7.24	7.40

Corium International Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.

Corium International (NAS:CORI) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.

Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.

Corium International Intangible Assets Related Terms

Thank you for viewing the detailed overview of Corium International's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Corium International (Corium International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corium International Inc (NAS:CORI) » Definitions » Intangible Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.coriumgroup.com

Corium International Inc is a commercial-stage biopharmaceutical company which is focused on the development, manufacture, and commercialization of specialty pharmaceutical products. The company has multiple proprietary programs in preclinical and clinical development focusing primarily on the treatment of neurological disorders. It has few proprietary transdermal platforms such as Corplex for small molecules and MicroCor which is a biodegradable microstructure technology for small molecules and biologics, including vaccines, peptides, and proteins. The company's products include Clonidine TDS, Fentanyl TDS, and Crest Whitestrips.

Executives

Essex Woodlands Health Ventures Fund Vii Lp	10 percent owner	21 WATERWAY AVENUE, SUITE 225, THE WOODLANDS TX 77380
Robert S Breuil	officer: Chief Financial Officer	2071 STIERLIN COURT, MOUNTAIN VIEW CA 94043
Bhaskar Chaudhuri	director	ONE ENTERPRISE, ALISO VIEJO CA 92656
Phyllis Gardner	director	618 MIRADA AVENUE, STANFORD CA 94305
Ronald W Eastman	director, 10 percent owner	335 BRYANT STREET, THIRD FLOOR, PALO ALTO CA 94301
Paul Goddard	director	ADOLOR CORPORATION, 700 PENNSYLVANIA DR., EXTON PA 19341
David Greenwood	director	230 CONSTITUTION DRIVE, MENLO PARK CA 94025
Ivan P. Gergel	director	C/O NEKTAR THERAPEUTICS, 455 MISSION BAY BLVD SOUTH, SAN FRANCISCO CA 94158
Peter D Staple	director, officer: President & CEO	863 C MITTEN ROAD, BURLINGAME CA 94010
Joseph J. Sarret	officer: Chief Business Officer	C/O CODEXIS, INC., 200 PENOBSCOT DRIVE, REDWOOD CITY CA 94063
Kevin Kotler	10 percent owner	C/O BROADFIN CAPITAL, LLC, 300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Broadfin Capital, Llc	10 percent owner	300 PARK AVENUE, 25TH FLOOR, NEW YORK NY 10022
Broadfin Healthcare Master Fund Ltd	10 percent owner	C/O 20 GENESIS CLOSE, ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344, GRAND CAYMAN E9 KY1-1108
Eric Bjerkholt	director	132 PURDURE AVENUE, KENGSINGTON CA 94708
Perceptive Life Sciences Master Fund Ltd	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003